These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. Heparanase: Historical Aspects and Future Perspectives. Khanna M; Parish CR Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707 [TBL] [Abstract][Full Text] [Related]
54. The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form. Boix E; Pulido D; Moussaoui M; Nogués MV; Russi S J Struct Biol; 2012 Jul; 179(1):1-9. PubMed ID: 22579681 [TBL] [Abstract][Full Text] [Related]
55. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells. Irimura T; Nakajima M; Nicolson GL Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351 [TBL] [Abstract][Full Text] [Related]
56. Human heparanase. Purification, characterization, cloning, and expression. Toyoshima M; Nakajima M J Biol Chem; 1999 Aug; 274(34):24153-60. PubMed ID: 10446189 [TBL] [Abstract][Full Text] [Related]
57. Molecular properties and involvement of heparanase in cancer progression and normal development. Vlodavsky I; Goldshmidt O; Zcharia E; Metzger S; Chajek-Shaul T; Atzmon R; Guatta-Rangini Z; Friedmann Y Biochimie; 2001 Aug; 83(8):831-9. PubMed ID: 11530216 [TBL] [Abstract][Full Text] [Related]
58. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis. Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586 [TBL] [Abstract][Full Text] [Related]
59. Human heparanase nuclear localization and enzymatic activity. Schubert SY; Ilan N; Shushy M; Ben-Izhak O; Vlodavsky I; Goldshmidt O Lab Invest; 2004 May; 84(5):535-44. PubMed ID: 15034597 [TBL] [Abstract][Full Text] [Related]